Showing 1 - 20 results of 46 for search 'American Association for Cancer Research', query time: 0.08s Refine Results
  1. 1

    Intersection of rare pathogenic variants from TCGA in the All of Us Research Program v6 by Blaine A. Bates, Kylee E. Bates, Spencer A. Boris, Colin Wessman, David Stone, Justin Bryan, Mary F. Davis, Matthew H. Bailey

    Published 2025-04-01
    “…Summary: Using rare cancer predisposition alleles derived from The Cancer Genome Atlas (TCGA) and high cancer prevalence (14% of participants) in All of Us (version 6), we assessed the impact of these rare alleles on cancer occurrence in six broad groups of genetic similarity provided by All of Us: African/African American (AFR), Admixed American/Latino (AMR), East Asian (EAS), European (EUR), Middle Eastern (MID), or South Asian (SAS). …”
    Get full text
    Article
  2. 2
  3. 3
  4. 4

    Pilot study: Initial investigation suggests differences in EMT-associated gene expression in breast tumor regions by Kylie L. King, Hamed Abdollahi, Zoe Dinkel, Alannah Akins, Homayoun Valafar, Heather Dunn

    Published 2025-01-01
    “…The development of breast cancer is highly associated with interactions between tumor cells and the extracellular matrix (ECM), and recent research suggests that cellular components of the ECM vary between racial groups. …”
    Get full text
    Article
  5. 5

    Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus by Hatia RI, Hwang LY, Li R, Troisi C, Jalal PK, Amos CI, Gomez HF, Chun YS, Rashid A, Kaseb AO, Scheet PA, Hassan MM

    Published 2025-01-01
    “…Compared with patients who had DM for 2– 10 years, those who had it for at least 20 years had an AOR of 4.60 (P = 0.04). Metformin use was associated with a reduced risk of death in HCC cases with type 2 DM, with a hazard ratio of 0.72 (P = 0.01) as compared with non-users.Conclusion: Our results demonstrate that type 2 DM was independently associated with increased risk of HCC among Mexican Americans. …”
    Get full text
    Article
  6. 6

    Recognition and Treatment of BCG Failure in Bladder Cancer by Andrew J. Lightfoot, Henry M. Rosevear, Michael A. O'Donnell

    Published 2011-01-01
    “…Thus, both the American Urological Association and European Association of Urology recommend initial intravesical treatment with bacillus Calmette-Guerin(BCG) followed by maintenance therapy for a minimum of 1 year. …”
    Get full text
    Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Helicobacter pylori and Biliary Tract Cancers: A Meta-Analysis by Soumia Cherif, Kaoutar Bouriat, Hanane Rais, Said Elantri, Abdessamad Amine

    Published 2020-01-01
    “…Epidemiological data on Helicobacter pylori infection and biliary tract cancer have been contradictory. Aim. The aim of this study is to explore and evaluate the association between the Helicobacter pylori infection and biliary tract cancer. …”
    Get full text
    Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Risk of Colorectal Cancer in Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis by Qing Zhou, Zhao-Feng Shen, Ben-sheng Wu, Cheng-biao Xu, Zhong-qi He, Tuo Chen, Hong-tao Shang, Chao-fan Xie, Si-yi Huang, Yu-gen Chen, Hai-bo Chen, Shu-tang Han

    Published 2019-01-01
    “…North American UC-associated CRC patients significantly increased in more than 30 years of this disease duration. …”
    Get full text
    Article
  17. 17
  18. 18

    Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy by Yiwen Qiu, Nida Cao, Dan Meng, Jian Yuan, Yingjie Zhu

    Published 2025-02-01
    “…Patients diagnosed with stage IV mCRC (per the American Joint Committee on Cancer [AJCC] 6th edition) between 2004 and 2015 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. …”
    Get full text
    Article
  19. 19
  20. 20